Aerosol Infection Model of Tuberculosis in Wistar Rats

Abstract EN

We explored suitability of a rat tuberculosis aerosol infection model for investigating the pharmacodynamics of new antimycobacterial agents.

Infection of rats via the aerosol route led to a reproducible course of M.

tuberculosis infection in the lungs.

The pulmonary bacterial load increased logarithmically during the first six weeks, thereafter, the infection stabilized for the next 12 weeks.

We observed macroscopically visible granulomas in the lungs with demonstrable acid-fast bacilli and associated histopathology.

Rifampicin (RIF) at a dose range of 30 to 270 mg/kg exhibited a sharp dose response while isoniazid (INH) at a dose range of 10 to 90 mg/kg and ethambutol (EMB) at 100 to 1000 mg/kg showed shallow dose responses.

Pyrazinamide (PZA) had no dose response between 300 and 1000 mg/kg dose range.

In a separate time kill study at fixed drug doses (RIF 90 mg/kg, INH 30 mg/kg, EMB 300 mg/kg, and PZA 300 mg/kg) the bactericidal effect of all the four drugs increased with longer duration of treatment from two weeks to four weeks.

The observed infection profile and therapeutic outcomes in this rat model suggest that it can be used as an additional, pharmacologically relevant efficacy model to develop novel antitubercular compounds at the interface of discovery and development.